logo

For the Inventor, By the Inventor

Kawasaki, Japan

Ryota Yoshimoto

This inventor holds 13 USPTO granted patents. Top assignee: Ajinomoto Co., Ltd.. Active years: 1988-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryota Yoshimoto. Retrieved from https://idiyas.com/inventor/ryota-yoshimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 84.6

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 124(Granted Patents)


Company Filing History:

goldMedal13 out of 1,953 
 
Ajinomoto Co., Ltd.
 patents

Years Active: 1988-2004

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6793920 - Antithrombotic agent and anti-von willebrand factor monoclonal antibody (2004-09-21),
2. 6476049 - Therapeutic agent for intermittent claudication (2002-11-05),
3. 6303635 - Thrombolytic drug (2001-10-16),
4. 6280731 - Antithrombotic agent and anti-von willebrand factor monoclonal antibody (2001-08-28),
5. 6262076 - Pharmaceutical composition for use in the treatment of diabetic neuropathy (2001-07-17),
6. 5932593 - Piperidine derivatives and anti-platelet agents containing the same (1999-08-03),
7. 5916805 - Antithrombotic agent and anti-von Willebrand factor monoclonal antibody (1999-06-29),
8. 5856126 - Peptide having anti-thrombus activity and method of producing the same (1999-01-05),
9. 5250681 - Piperidine derivatives and hypotensives containing the same (1993-10-05),
10. 5231105 - Ethylamine derivatives and antihypertensives containing the same (1993-07-27),
11. 5229400 - Piperidine compounds and their use as antiarrhythmic agents (1993-07-20),
12. 4789658 - Immunoprophylactic and immunotherapeutic agents (1988-12-06),
13. 4772572 - Hybridomas and monoclonal antibodies to human IL-2 (1988-09-20),

Title: The Innovative Contributions of Ryota Yoshimoto

Introduction

Ryota Yoshimoto is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of medicine, particularly in the development of therapeutic agents. With a total of 13 patents to his name, Yoshimoto's work has the potential to impact patient care and treatment options.

Latest Patents

Among his latest patents, Yoshimoto has developed an antithrombotic agent and an anti-von Willebrand factor monoclonal antibody. This monoclonal antibody exhibits reactivity with human von Willebrand factor and inhibits various forms of platelet aggregation without causing bleeding action at medicinally effective doses. Another notable patent is a therapeutic agent for intermittent claudication, which involves a specific compound that provides treatment for patients suffering from this condition.

Career Highlights

Yoshimoto is currently employed at Ajinomoto Co., Ltd., where he continues to innovate and contribute to the field of pharmaceuticals. His work is characterized by a commitment to improving therapeutic options for patients, showcasing his dedication to medical advancements.

Collaborations

Yoshimoto collaborates with esteemed colleagues, including Hiroshi Yamamoto and Mitsuyo Nagano. These partnerships enhance the research and development process, allowing for a more comprehensive approach to innovation.

Conclusion

Ryota Yoshimoto's contributions to the field of medicine through his patents and collaborations highlight his role as a key inventor. His work not only advances scientific knowledge but also aims to improve patient outcomes in critical areas of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…